Ian Walters
Chief Executive Officer chez PORTAGE BIOTECH INC.
Fortune : 216 510 $ au 31/03/2024
Profil
Ian B.
Walters founded SalvaRx Group Plc in 2007, where he worked as Chief Executive Officer in 2019.
Dr. Walters also currently works at Portage Biotech, Inc., as Chairman & Chief Executive Officer from 2022, SalvaRx Ltd., as Chief Executive Officer, Stimunity SAS, as Chairman, Enzo Biochem, Inc., as Independent Director from 2020, and iOX Therapeutics Ltd., as Director from 2015.
Dr. Walters also formerly worked at Bristol Myers Squibb Co., as Executive Director-Global Oncology Clinical, Millennium Pharmaceuticals, Inc., as Medical Director, 3Legs Resources Plc, as Director, RIFT biotherapeutics, Inc., as Director, Sorrento Therapeutics, Inc., as SVP-Translational Medicine & Corporate Development, Bristol-Myers Squibb Canada Co., as Member from 2007 to 2014, and Intensity Therapeutics, Inc., as Chief Medical Officer & Vice President from 2014 to 2023.
Dr. Walters received his doctorate degree in 1993 from Albert Einstein College of Medicine, Inc. and Masters Business Admin degree in 2003 from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PORTAGE BIOTECH INC
1,25% | 31/03/2023 | 246 516 ( 1,25% ) | 138 789 $ | 31/03/2024 |
ENZO BIOCHEM, INC.
0,12% | 08/12/2023 | 61 198 ( 0,12% ) | 77 721 $ | 31/03/2024 |
Postes actifs de Ian Walters
| Sociétés | Poste | Début |
|---|---|---|
| PORTAGE BIOTECH INC. | Chief Executive Officer | 06/05/2019 |
| ENZO BIOCHEM, INC. | Director/Board Member | 25/11/2020 |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | 01/07/2015 |
Stimunity SAS
 Stimunity SAS BiotechnologyHealth Technology Stimunity SAS provides biotechnology services. The company is based in Paris, France. The French company was founded in 2016 by Sylvain Carlioz, Nicolas Manel. Sylvain Carlioz has been the CEO since 2016. | Chairman | - |
SalvaRx Ltd.
 SalvaRx Ltd. BiotechnologyHealth Technology SalvaRx Ltd. develops and provides treatment in the field of cancer immunology. The company is headquartered in London, the United Kingdom. | Chief Executive Officer | - |
Anciens postes connus de Ian Walters
| Sociétés | Poste | Fin |
|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2023 |
| SALVARX GROUP PLC | Founder | 08/01/2019 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Chief Operating Officer | 01/03/2014 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Ian Walters
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ENZO BIOCHEM, INC. | Health Technology |
| PORTAGE BIOTECH INC. | Health Technology |
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
3Legs Resources Plc
 3Legs Resources Plc Financial ConglomeratesFinance 3Legs Resources Plc engages in the provision of investing in acquire companies within the technology sector. It includes interest in a proposed investment and acquisition. The company was founded on July 22, 2002 and is headquartered in Ramsey, Isle of Man. | Finance |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Health Technology |
SalvaRx Ltd.
SalvaRx Ltd. BiotechnologyHealth Technology SalvaRx Ltd. develops and provides treatment in the field of cancer immunology. The company is headquartered in London, the United Kingdom. | Health Technology |
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc BiotechnologyHealth Technology SalvaRx Group Plc engages in the development of drug that focuses on cancer immune-oncology. Its products portfolio includes iOx therapeutics, intensity therapeutics, nekonal oncology, and rift biotherapeutics. The company was founded by Ian B. Walters and Robert A. Kramer in 2007 and is headquartered in Ramsey, Isle of Man. | Health Technology |
RIFT biotherapeutics, Inc.
 RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services RIFT biotherapeutics, Inc. operates as a therapeutic antibody company that focuses on immuno-oncology targets outside of the T-cell space. It generates therapeutic antibodies that harness the immune system, to target cancers in areas of unmet needs. The company was founded by Miguel A. de los Ríos, Cornelia Bentley, and Jeff Pitman in 2015 and is headquartered in San Diego, CA. | Commercial Services |
Stimunity SAS
Stimunity SAS BiotechnologyHealth Technology Stimunity SAS provides biotechnology services. The company is based in Paris, France. The French company was founded in 2016 by Sylvain Carlioz, Nicolas Manel. Sylvain Carlioz has been the CEO since 2016. | Health Technology |
